These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 26644009

  • 21. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
    Xu R, Kido S, Suga K, Hirano Y, Tachibana R, Muramatsu K, Chagawa K, Tanaka S.
    Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
    [Abstract] [Full Text] [Related]

  • 22. [Use of 18F-FDG-positron emission tomography in presurgical evaluation of nonspecific or suspectious adrenal masses in non-oncologic patients].
    Pavón-Paz I, Rosado-Sierra JA, Balsa-Bretón MÁ, Guijarro-Armas G, Merino-Viveros M, Penín-Gonzalez FJ.
    Med Clin (Barc); 2016 Feb 05; 146(3):104-7. PubMed ID: 26343158
    [Abstract] [Full Text] [Related]

  • 23. Semiquantitative Assessment of 18F-FDG Uptake in the Normal Skeleton: Comparison Between PET/CT and Time-of-Flight Simultaneous PET/MRI.
    Minamimoto R, Xu G, Jamali M, Holley D, Barkhodari A, Zaharchuk G, Iagaru A.
    AJR Am J Roentgenol; 2017 Nov 05; 209(5):1136-1142. PubMed ID: 28777652
    [Abstract] [Full Text] [Related]

  • 24. Predicting malignancy in patients with adrenal tumors using 18 F-FDG-PET/CT SUVmax.
    Vos EL, Grewal RK, Russo AE, Reidy-Lagunes D, Untch BR, Gavane SC, Boucai L, Geer E, Gopalan A, Chou JF, Capanu M, Strong VE.
    J Surg Oncol; 2020 Dec 05; 122(8):1821-1826. PubMed ID: 32914407
    [Abstract] [Full Text] [Related]

  • 25. FDG-PET and CT characterization of adrenal lesions in cancer patients.
    Jana S, Zhang T, Milstein DM, Isasi CR, Blaufox MD.
    Eur J Nucl Med Mol Imaging; 2006 Jan 05; 33(1):29-35. PubMed ID: 16193311
    [Abstract] [Full Text] [Related]

  • 26. Adrenal tracer uptake by 18F-FDOPA PET/CT in patients with pheochromocytoma and controls.
    Noordzij W, Glaudemans AWJM, Schaafsma M, van der Horst-Schrivers ANA, Slart RHJA, van Beek AP, Kerstens MN.
    Eur J Nucl Med Mol Imaging; 2019 Jul 05; 46(7):1560-1566. PubMed ID: 31011769
    [Abstract] [Full Text] [Related]

  • 27. Diagnostic performance of 18-F-FDG-PET-CT in adrenal lesions using histopathology as reference standard.
    Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS.
    Abdom Radiol (NY); 2017 Feb 05; 42(2):577-584. PubMed ID: 27665482
    [Abstract] [Full Text] [Related]

  • 28. High False Positivity in Positron Emission Tomography is a Potential Diagnostic Pitfall in Patients with Suspected Adrenal Metastasis.
    Lang BH, Cowling BJ, Li JY, Wong KP, Wan KY.
    World J Surg; 2015 Aug 05; 39(8):1902-8. PubMed ID: 25809060
    [Abstract] [Full Text] [Related]

  • 29. Characterization of lipid-rich adrenal tumors by FDG PET/CT: Are they hormone-secreting or not?
    Takanami K, Kaneta T, Morimoto R, Satoh F, Nakamura Y, Takase K, Takahashi S.
    Ann Nucl Med; 2014 Feb 05; 28(2):145-53. PubMed ID: 24272068
    [Abstract] [Full Text] [Related]

  • 30. Characterization of adrenocortical tumors by 18F-FDG PET/CT: Does steroid hormone hypersecretion status modify the uptake pattern?
    Paladino NC, Guérin C, Lowery A, Attard A, Essamet W, Slotema E, Morange I, Castinetti F, Brue T, Loundou A, Taïeb D, Sebag F.
    Surg Oncol; 2018 Jun 05; 27(2):231-235. PubMed ID: 29937176
    [Abstract] [Full Text] [Related]

  • 31. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
    Blake MA, Slattery JM, Kalra MK, Halpern EF, Fischman AJ, Mueller PR, Boland GW.
    Radiology; 2006 Mar 05; 238(3):970-7. PubMed ID: 16505394
    [Abstract] [Full Text] [Related]

  • 32. The value of intratumoral heterogeneity of (18)F-FDG uptake to differentiate between primary benign and malignant musculoskeletal tumours on PET/CT.
    Nakajo M, Nakajo M, Jinguji M, Fukukura Y, Nakabeppu Y, Tani A, Yoshiura T.
    Br J Radiol; 2015 Mar 05; 88(1055):20150552. PubMed ID: 26337605
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic value of metabolic tumor volume assessed by 18F-FDG PET/CT added to SUVmax for characterization of thyroid 18F-FDG incidentaloma.
    Kim BH, Kim SJ, Kim H, Jeon YK, Kim SS, Kim IJ, Kim YK.
    Nucl Med Commun; 2013 Sep 05; 34(9):868-76. PubMed ID: 23797273
    [Abstract] [Full Text] [Related]

  • 34. Does 18F-FDG PET/MRI reduce the number of indeterminate abdominal incidentalomas compared with 18F-FDG PET/CT?
    Schaarschmidt BM, Grueneisen J, Heusch P, Gomez B, Umutlu L, Ruhlmann V, Rosenbaum-Krumme S, Antoch G, Buchbender C.
    Nucl Med Commun; 2015 Jun 05; 36(6):588-95. PubMed ID: 25759944
    [Abstract] [Full Text] [Related]

  • 35. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in the characterization of pancreatic masses: experience from tropics.
    Santhosh S, Mittal BR, Bhasin D, Srinivasan R, Rana S, Das A, Nada R, Bhattacharya A, Gupta R, Kapoor R.
    J Gastroenterol Hepatol; 2013 Feb 05; 28(2):255-61. PubMed ID: 23278193
    [Abstract] [Full Text] [Related]

  • 36. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW, Xu BX, Wang RM, Sun L, Tian JH.
    Hell J Nucl Med; 2013 Feb 05; 16(2):97-102. PubMed ID: 23687644
    [Abstract] [Full Text] [Related]

  • 37. The value of dual time point (18)F-FDG PET imaging for the differentiation between malignant and benign lesions.
    Lan XL, Zhang YX, Wu ZJ, Jia Q, Wei H, Gao ZR.
    Clin Radiol; 2008 Jul 05; 63(7):756-64. PubMed ID: 18555033
    [Abstract] [Full Text] [Related]

  • 38. Serial changes of FDG uptake and diagnosis of suspected lung malignancy: a lesion-based analysis.
    Cheng G, Alavi A, Werner TJ, Del Bello CV, Akers SR.
    Clin Nucl Med; 2014 Feb 05; 39(2):147-55. PubMed ID: 24368534
    [Abstract] [Full Text] [Related]

  • 39. FDG-PET/CT characterization of adrenal nodules: diagnostic accuracy and interreader agreement using quantitative and qualitative methods.
    Evans PD, Miller CM, Marin D, Stinnett SS, Wong TZ, Paulson EK, Ho LM.
    Acad Radiol; 2013 Aug 05; 20(8):923-9. PubMed ID: 23830599
    [Abstract] [Full Text] [Related]

  • 40. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Derlin T, Tornquist K, Münster S, Apostolova I, Hagel C, Friedrich RE, Wedegärtner U, Mautner VF.
    Clin Nucl Med; 2013 Jan 05; 38(1):e19-25. PubMed ID: 23242059
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.